Perylenequinones: Fungal metabolites under the spotlight

View at publisher
Authors: Nicholas H. Oberlies
Cited by: 0
References: 2

Abstract

Fungal metabolites are well known for providing humanity with medical benefits, with penicillin and the antibiotics revolution that it stimulated probably one of the greatest examples. Interestingly, some of these molecules display a high level of conjugation, and as such, can be considered redox active metabolites (i.e., RAMs). With a diverse group of collaborators, we have been studying ways to harness the redox properties of fungal, [ Fig. 1 ] [ ] perylenequinones, specifically hypocrellins, [ Fig. ] [ 2 ] [ i.e ., ent -Shiraiachrome A (1)] and hypomycins [ i.e ., hypomycin C (5)], towards applications in photodynamic therapy and photocatalysis [ 1 ] [ 2 ]. This talk will present our understanding of these molecules, ranging from fermentation optimization studies to harnessing their redox potential in a variety of applications. Fig. 1 Structure of ent -shiraiachrome A (1) Fig. 2 Structure of hypomycin C (5) Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Fields of Study & Subjects

Microbial Natural Products and Biosynthesis Microbial Metabolism and Applications Bioactive Compounds and Antitumor Agents

Publication details

Journal / source
Planta Medica
Volume
92
Publication date
1 March 2026
Language
EN